| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.4M | -34.7% | +91.6% |
| SG&A Expense | $3.9M | +0.0% | -15.8% |
| Operating Income | -$13.3M | +27.3% | -167.0% |
| Pre-tax Income | -$12.8M | +27.6% | -227.2% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$12.8M | +27.6% | -227.2% |
| EPS (Basic) | -$0.32 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.4M | -22.6% | -72.6% |
| Short-term Investments | $16.9M | -31.8% | — |
| Current Assets | $39.9M | -21.1% | -50.0% |
| Total Assets | $41.3M | -20.8% | -49.3% |
| Current Liabilities | $8.4M | +0.7% | +48.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.3M | — | — |
| Capital Expenditures | $6K | — | — |
| Investing Cash Flow | -$16.7M | — | — |
| Financing Cash Flow | $18K | — | — |
| Free Cash Flow | -$33.3M | — | — |
| +27.3% |
| -220.0% |
| EPS (Diluted) | -$0.32 | +27.3% | -220.0% |
| $8.5M |
| +0.0% |
| +48.1% |
| Stockholders' Equity | $32.8M | -24.8% | -56.7% |